Compositions for treating arterial thrombosis and a factor Xa inhibitor
US6541488B1 · kind B1 · utility
4Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 11, 2000 |
| Grant date | Apr 1, 2003 |
| Priority date | — |
| Expiry date | Feb 11, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of direct or indirect selective inhibitors of factor Xa acting via antithrombin III, alone or in combination with one or more compounds with anti-platelet aggregation activity, for the preparation of medicines intended to prevent and to treat thromboembolic arterial diseases.The subject of the invention is also pharmaceutical compositions containing one or more direct or indirect selective inhibitors of factor Xa which act via antithrombin III in combination with one or more compounds with anti-platelet aggregation activity, and optionally one or more pharmaceutically acceptable vehicles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.